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ABSTRACT
Polycomb group (PcG) proteins are key regulators
of stem-cell and cancer biology. They mainly act
as repressors of differentiation and tumor-
suppressor genes. One key silencing step involves
the trimethylation of histone H3 on Lys27 (H3K27)
by EZH2, a core component of the Polycomb
Repressive Complex 2 (PRC2). The mechanism
underlying the initial recruitment of mammalian
PRC2 complexes is not well understood. Here, we
show that NIPP1, a regulator of protein Ser/Thr
phosphatase-1 (PP1), forms a complex with PP1
and PRC2 components on chromatin. The knock-
down of NIPP1 or PP1 reduced the association of
EZH2 with a subset of its target genes, whereas the
overexpression of NIPP1 resulted in a retargeting of
EZH2 from fully repressed to partially active PcG
targets. However, the expression of a PP1-binding
mutant of NIPP1 (NIPP1m) did not cause a redistri-
bution of EZH2. Moreover, mapping of the chromatin
binding sites with the DamID technique revealed that
NIPP1 was associated with multiple PcG target
genes, including the Homeobox A cluster, whereas
NIPP1m showed a deficient binding at these loci.
We propose that NIPP1 associates with a subset
of PcG targets in a PP1-dependent manner and
thereby contributes to the recruitment of the PRC2
complex.
INTRODUCTION
Polycomb group proteins are essential regulators of
embryonic development and stem-cell maintenance (1–3),
and their deregulation contributes to cancer (4,5). PcG
proteins function as transcriptional silencers of a large
set of genes, many of which are key determinants
of proliferation and differentiation. PcG-mediated
silencing involves two types of complexes, known as
the Polycomb Repressive Complexes (PRC) 1 and 2.
PRC2-type complexes initiate gene silencing through
trimethylation of histone H3 on Lys27 (H3K27me3) by en-
hancer of zeste 2 (EZH2). Other PRC2 components,
including embryonic ectoderm development (EED) and
suppressor of zeste 12 homolog (SUZ12), function
as activators of EZH2. Trimethylated H3K27 serves as
a docking site for the initial recruitment of PRC1-type
complexes, which execute gene silencing. According
to one model, PRC1 complexes hamper transcriptional
elongation by RNA polymerase II, possibly as a result
of their ability to compact chromatin or ubiquitylate
histone H2A (3).
The mechanism underlying the recruitment of PRC
complexes to their targets is only partially understood
(3,5). In Drosophila, the targeting of PRC complexes
depends on the combinatorial action of multiple
DNA-binding proteins, including Pleiohomeotic (Pho)
and Pho-like protein, which bind at or near Polycomb
Responsive Elements (PREs) on PcG target sites. Recent
data suggest that mammalian PcG targets also harbor
PREs (6,7), but there is also substantial evidence
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complexes (2,3,5,8). The DNA-binding protein YY1, the
mammalian ortholog of Pho, interacts with the PRC2
component EED and has been implicated in the recruit-
ment of PRC2 (9). However, only a minor overlap was
noted between the binding sites of YY1 and PRC2 (10),
indicating that YY1 does not function as the sole PRC2
recruiter. Recently, it was shown that the DNA-binding
protein JARID2 regulates PRC2 recruitment in ES cells
(11,12). Collectively, these data suggest that a variety of
transcription factors may be implicated in the recruitment
of PcG complexes in a combinatorial and tissue-speciﬁc
manner (3,5,11,12). Finally, it has also been shown that
PRC2 core components interact directly with H3K27me3
(13,14), which may serve as a maintenance mechanism for
the propagation of the H3K27me3 mark to unmodiﬁed
nucleosomes during DNA replication.
NIPP1 (38kDa) was initially characterized as
an RNA-associated nuclear interactor of protein Ser/Thr
phosphatase-1 (15,16). Later investigations identiﬁed
additional direct NIPP1 ligands, including the PRC2
core components EZH2 and EED, and revealed that
NIPP1 functions as a PRC2-dependent transcriptional
repressor in reporter assays (17,18). In addition, NIPP1
was found to be enriched at PcG targets and a deﬁciency
of NIPP1 in blastocysts or cultured cells was associated
with a reduced global trimethylation of H3K27 and
a derepression of an important subset of PcG targets
(19), indicating that NIPP1 is essential for PcG-mediated
repression in vivo. In further agreement with this view,
mouse embryos lacking NIPP1 die at around the gastru-
lation stage (20), a phenotype that is similar to that
associated with the loss of the PRC2 core components
EZH2, EED or SUZ12 (2).
Since NIPP1 interacts directly with both nucleic acids
and PRC2 components, it emerged as an attractive candi-
date regulator of PRC2 binding to chromatin. Consistent
with this notion, we show here that the loss of NIPP1
results in a reduced occupancy of EZH2 at a subset
of PcG targets, whereas the overexpression of NIPP1
causes, in a PP1-dependent manner, a redistribution of
EZH2 between its target genes. We also demonstrate
that NIPP1-associated PP1 is not involved in the
assembly of the PRC2 complex but is required for its
translocation to a subset of PcG targets. Our results
provide novel insights into the regulation of the chromatin
recruitment of PRC2-type complexes and demonstrate
links between PcG-mediated gene silencing and PP1
signaling.
MATERIALS AND METHODS
Antibodies
For chromatin immunoprecipitation (ChIP) experiments
anti-H3K27Me3 (07-449), anti-EZH2 (39103 and 39639)
and rabbit anti-mouse immunoglobulins (IgG) were
obtained from Upstate (Dundee, UK), Active motif
(Rixensart, Belgium) and DakoCytomation (Gostrup,
Denmark), respectively. For immunoblot analysis
anti-Histone H3 (ab1791), anti-RbAp48 (ab488) and
anti-TATA binding protein (ab51841) were obtained
from Abcam (Cambridge, UK). Anti-SUZ12 (clone
3C1.2), mouse anti-EZH2 (AC-22) and mouse
anti-NIPP1 (612368) were purchased from Millipore
(Billerica, MA, USA), Cell Signaling Technology
(Danvers, MA, USA) and BD Biosciences (San Jose,
CA, USA), respectively, and anti-a-tubulin (clone
B-5-1-2) and anti-Flag (M2, 200472-21) from
Sigma-Aldrich (St. Louis, MO, USA). Anti-GFP (SC-
8334) was purchased from Santa Cruz (Santa Cruz,
California, USA). Monoclonal anti-PP1 antibodies,
which recognize all isoforms of PP1, were puriﬁed on
protein-A Sepharose CL-4B (GE Healthcare). The
hybridoma clone producing these antibodies was a kind
gift of Dr. J. Vandenheede (University of Leuven).
Synthetic fragments of human NIPP1 (341-
PGKKPTPSLLI-351), coupled to keyhole limpet hemo-
cyanin, were used to generate polyclonal antibodies in
rabbits and were used for immunoprecipitation. The
antibodies were afﬁnity-puriﬁed on the bovine serum
albumin-coupled peptides linked to CNBr-activated
Sepharose 4B. Human recombinant polyhistidine-tagged
EED was used to raise antibodies in rabbits as previously
described (17). Subsequently, EED antibodies were
coupled to HRP by the Lightning-Link HRP conjugation
kit (Innova Biosciences, Cambridge, UK).
Cell culture and knockdowns
PC-3 cells were cultured in 50% Dulbecco’s modiﬁed
Eagle’s medium (DMEM) and 50% Ham’s F12 with
10% fetal calf serum (FCS), HEK293T and HeLa cells
were cultured in DMEM complemented with 10% FCS.
The culture conditions of HTO cells are described in (21).
Transfection with plasmid DNA was carried out with
Fugene-6 Transfection Reagent (Roche Applied
Science). Plasmids encoding EGFP, NIPP1-EGFP and
NIPP1m-EGFP have been previously described (22).
In the PP1-binding mutant (NIPP1m-EGFP) the
RVxF-type PP1 binding motif was mutated (V201A/
F203A).
SiRNA duplexes against human NIPP1 and scrambled
control siRNAs were purchased from Invitrogen (Paisley,
UK). SiRNA duplexes against human PP1a, PP1b, PP1g
and control siRNAs were obtained from Dharmacon
(Chicago, IL, USA). Sequences of the siRNAs are
described in the Supplementary Data. Knockdowns were
performed using Lipofectamine 2000 (Invitrogen) and
were analyzed after 48h, as described in (19).
ChIP and DNA adenine methyltransferase identiﬁcation
ChIP assays were performed as described in (19). DNA
adenine methyltransferase identiﬁcation (DamID) was
essentially performed as described in (23). In brief, HeLa
cells were stably transfected with constructs derived from
pIND-(V5)-EcoDam (24), expressing trace amounts of
Dam or C-terminal fusions with full-length wild-type
NIPP1 and its PP1-binding mutant (NIPP1-(1-351)-
V201A/F203A), leading to methylation of genomic
DNA at sites of the fusion proteins’ association with
chromatin. Genomic DNA was extracted and processed
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Puriﬁed DNA was analyzed by quantitative PCR,
as described for ChIP, or by microarray analysis.
Sequences of primers are given as Supplementary Data.
To verify the expression of the full-length Dam-fusion
proteins, HEK293T cells were co-transfected with the
pIND-(V5)-EcoDam-NIPP1 (WT and mutant) construct
and the receptor-transcription factor encoding plasmid
pVgRXR (Invitrogen). 20h post transfection, 2mMo f
ponasterone A (Invitrogen) was added and the cells were
harvested 24h later. Total cell lysates in SDS sample
buffer were subjected to immunoblotting, detecting
endogenous NIPP1 and Dam-fusions with antibodies
against NIPP1.
Microarray analysis
Microarray handling, quality control and analysis were
performed by the VIB MicroArray Facility in Belgium
(www.microarrays.be) and were essentially performed
as described in (19). In brief, for the genome-wide gene
expression proﬁling, the RNA from HTO-PT,
HTO-NIPP1 and HTO-NIPP1m cell lines from four
different experiments were isolated, labeled with a ﬂuor-
escent dye and hybridized onto Whole Human Genome
Oligo microarrays from Agilent (Santa Clara, CA, USA).
The data from the parent cell line were used as baseline
expression for comparison with the Flag-NIPP1
and Flag-NIPP1m cell lines. All gene expression
data are available at GEO under the accession number
GSE19642.
For the genome-wide chromatin proﬁling, the DamID-
DNA was labeled and hybridized to a GeneChIP
ENCODE 2.0R array (Affymetrix, Santa Clara, CA,
USA). The array read-out was analyzed with the MAT
algorithm to detect enriched genomic regions for
Dam-NIPP1 and Dam-NIPP1m binding in relation
to the Dam-only control (25). Signal traces and regions
of signiﬁcant enrichment were visualized using
the Integrated Genome Browser 512m provided
by Affymetrix. All damID data are available at GEO
under the accession number GSE22123.
Biochemical procedures
PC-3 cells were harvested and lysed for 30–45min at 4C
in buffer A (50mM Tris–HCl at pH 7.5, 0.5mM
phenylmethanesulfonyl ﬂuoride (PMSF), 0.5mM
benzamidine, 5mM leupeptin, 1mM dithiothreitol,
20mM NaF), supplemented with 0.5% Triton X-100.
Centrifugation of the lysates (10min at 1800g) yielded
a supernatant (S) and pellet (P). The pellets were washed
twice with buffer A. For the chromatin association assay
(Figure 1B), the pellet was incubated for 30min at 10Ci n
a shaking incubator in the presence of buffer A, without
or with 20mM His-NIPP1. Recombinant His-NIPP1 was
puriﬁed from Escherichia coli as described in (26).
For the immunoprecipitation assays in PC-3 cells
(Figure 1A), the washed chromatin pellets were resus-
pended in 50mM Tris–HCl at pH 8, supplemented
with 1.5mM CaCl2 and 20mM NaF, and treated with
30U of micrococcal nuclease (Fermentas, GmBH,
St Leon-Rot, Germany) for 30min at 37C. The soluble
and insoluble fractions were separated by centrifugation
(2min at 664g). The solubilized chromatin fraction (P)
and the combined fractions of nucleoplasm and cytoplasm
(S) were incubated for 2h at 4C with polyclonal
anti-NIPP1 or anti-EZH2 antibodies and anti-mouse
IgG for control. Subsequently, 30ml of protein-A-TSK
beads (1:1 suspension) were added for 1h at 4C. After
centrifugation (30s at 425g) the pellet was washed four to
six times with Tris-buffered saline (TBS), supplemented
with 0.1% Triton X-100 and 0.25% NP-40, and subjected
to immunoblotting.
For the immunoprecipitations in HEK293T cells
(Figure 7), the micrococcal nuclease-solubilized chromatin
fraction was obtained as described for the PC-3
cells. Subsequently, the solubilized chromatin fraction
(P) was incubated for 2–3h at 4C with 25mlo f
GFP-Trap beads (1:1 suspension, Chromotek,
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Figure 1. NIPP1 forms a complex with PP1 and PRC2 components on chromatin. (A) NIPP1 and EHZ2 were immunoprecipitated from the
combined cytoplasmic + nucleoplasmic fractions (S) and the micrococcal nuclease-solubilized chromatin fraction (P) of PC-3 cells. Anti-mouse
IgGs were used as negative control for the immunoprecipitation (Ctr). NIPP1, PP1, EZH2, SUZ12 and RBAp48 were detected by immunoblotting in
the input (In, 5%) and the immunoprecipitates (IP). (B) The resuspended chromatin pellet of PC-3 cells was incubated for 30min at 10C, as such
(buffer) or with 20mM His-NIPP1. Subsequently, the insoluble fraction was resedimented. The ﬁgure shows an immunoblot of PP1, EZH2, SUZ12,
RBAp48 and H3 in the input (In, 100%), supernatant (S) and pellet (P).
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antibodies or anti-mouse IgG (Control). In the last two
conditions, 30ml of protein-A-TSK beads (1:1 suspension)
were added for 1h at 4C. Washing conditions were iden-
tical to that used for PC-3 cells.
HTO cells (Figure 3C) were seeded and cultured for 48h
without doxycyclin. After harvesting, the cells were
washed twice in PBS and lysed in buffer containing
50mM Tris–HCl at pH 7.5, 0.3M NaCl, 0.5 % Triton
X-100, 1mM PMSF, 1mM benzamidine and 5mM
leupeptin for 15min at 10C. The lysates were clariﬁed
by centrifugation (10min at 3800g). Aliquots of cell
lysates (1.7mg protein) were incubated for 2h at 4C
with monoclonal anti-Flag-M2 antibodies and polyclonal
anti-mouse IgGs. Subsequently, 30ml of protein-A-TSK
beads (1:1 suspension) were added for 1h at 4C. After
centrifugation (20s at 425g) the pellet was washed once
with TBS supplemented with 0.1M LiCl, twice with TBS
supplemented with 0.1% NP-40, and then processed for
immunoblotting. For the fractionation of HTO cells
(Figure 3D), cells were lysed in buffer A, supplemented
with 0.5% Triton X-100, for 45min at 4C and then
centrifugated for 5min at 1700g. This yielded
a supernatant (Sol) and the chromatin pellet (Chrom).
The pellets were washed twice with buffer A, dissolved
in SDS sample buffer and sonicated for 30min at 30-s
intervals.
RESULTS
Identiﬁcation of a chromatin-associated complex of
NIPP1, PP1 and PRC2
We have previously demonstrated that NIPP1 has dis-
tinct binding sites for PP1, EZH2 and EED, and
is implicated in PRC2-mediated regulation of gene expres-
sion (17–19,22). To explore the possible role of NIPP1 and
PP1 in the binding of the PRC2 complex to chromatin,
we ﬁrst compared their interaction in the soluble and
chromatin fractions of human prostatic carcinoma
(PC-3) cells. The PRC2 components EZH2, SUZ12 and
RbAp48 co-immunoprecipitated with NIPP1 from
a chromatin extract, but not from the combined cytoplas-
mic and nucleoplasmic fractions (Figure 1A). Conversely,
the PRC2 components co-immunoprecipitated with EZH2
from both the soluble and chromatin fractions, but NIPP1
only co-precipitated from the chromatin extract. Finally,
PP1 co-immunoprecipitated with both NIPP1 and EZH2
from the soluble and chromatin fractions. These data
pointed to the existence of a chromatin-associated
complex that comprises NIPP1, PP1 and PRC2
components. In further agreement with this interpretation,
we found that the mere incubation of the chromatin
fraction with an excess of bacterially expressed and
puriﬁed NIPP1 competitively disrupted the association
of EZH2, SUZ12, RbAp48 and PP1 with the chromatin
pellet, but did not solubilize histone H3 (Figure 1B).
The loss of NIPP1 or PP1 reduces the targeting of EZH2
To further delineate the contribution of NIPP1 and
associated PP1 to the binding of the PRC2 complex with
chromatin in PC-3 cells, we examined the effect of the
siRNA-mediated knockdown of either NIPP1 or PP1
(all three isoforms) on the chromatin targeting of
EZH2. qRT-PCR (not shown) and immunoblot analysis
(Figure 2A) showed that the transcript and protein levels
of NIPP1 and PP1 could be efﬁciently reduced without
signiﬁcant effects on the concentration of EZH2. Four
genes were selected to examine the effect of the
knockdowns on EZH2 recruitment, namely RPS6KC1,
NMU and MYT1, three previously established NIPP1
target genes in PC-3 cells (19), and CDC6, which was
used as a negative control. ChIP analysis conﬁrmed that
EZH2 (Figure 2B) and H3K27me3 (Figure 2C) were
enriched at the promoter region of RPS6KC1, NMU
and MYT1. Consistent with a role for NIPP1 and PP1
in the binding of EZH2 to these target genes,
the knockdown of either NIPP1 or PP1 resulted in a signiﬁ-
cantly reduced association of EZH2 with the latter three
loci (Figure 2D) and a corresponding decrease in the level
of H3K27me3 (Figure 2E).
The overexpression of NIPP1 redistributes EZH2
Next, we took a reverse approach and explored the effect
of an overexpression of NIPP1 on the association of EZH2
with its target genes. For this purpose, we ﬁrst
characterized HeLa Tet-Off (HTO) cell lines that were en-
gineered to stably express Flag-tagged wild type NIPP1
(Flag-NIPP1) or a point mutant (Flag-NIPP1m) with
a disrupted PP1-docking motif (Figure 3A). The Flag
fusions were only expressed in the absence of doxycyline
and at levels that were up to 2-fold higher than that
of endogenous NIPP1 (Figure 3B). Moreover, their
expression did not affect the concentration of EZH2 and
PP1. Co-immunoprecipitation analysis conﬁrmed
that Flag-NIPP1, but not Flag-NIPP1m, was associated
with PP1 in HTO cell lysates (Figure 3C). However,
Flag-NIPP1 and Flag-NIPP1m fractionated to a similar
extent with the chromatin fraction (Figure 3D). We also
performedageneexpressionproﬁlingoftheHTOcelllines,
using whole human genome oligo microarrays from
Agilent. A paired SAM analysis identiﬁed 1365 genes
with an altered expression (P<0.01) between the
Flag-NIPP1 and parental cell lines (Figure 3E,
Supplementary Table S1). Importantly, only 185 genes
were differentially expressed (P<0.01) between the
Flag-NIPP1m and parental cell lines (Figure 3E,
Supplementary Table S2). Even more strikingly, only 5%
of the genes that were affected by the expression
of Flag-NIPP1 also showed a signiﬁcantly different expres-
sion in the Flag-NIPP1m cells (Figure 3E). A similar small
overlapwasnotedwhentheanalysiswasrestrictedtothe50
genes that were most upregulated or downregulated by the
expression of Flag-NIPP1 (Figure 3F). Finally, scatter plot
analysis revealed no signiﬁcant correlation between the
genes that were affected by the expression of Flag-NIPP1
orFlag-NIPP1m(Figure3G).Collectively,thesedatadem-
onstrate that a moderate increase in the concentration of
NIPP1affectstheexpressionofnumerous genesbyamech-
anism that depends on associated PP1.
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genes, we made use of a list of 2206 PcG target genes,
as derived from a genome-wide analysis of the distribution
of H3K27 trimethylation in TIG3 cells (27). Using
this list, 72 of the affected genes in the Flag-NIPP1
expressing HTO cells were classiﬁed as likely PcG
targets (Supplementary Table S3). However, it should
be realized that the actual number of NIPP1-associated
PcG target genes is probably much higher since only
a minor fraction of PcG targets show an altered expres-
sion when the concentration of key PcG components
is reduced (27). This has been explained by the permanent
silencing of the majority of PcG targets due to secondary
epigenetic modiﬁcations of the target promoters. Among
these 72 putative PcG targets with altered expression,
we selected six genes for further analysis, i.e. three genes
that were repressed (FOXA1, MT1F and C15ORF27) and
three genes that were overexpressed (ITGB2, CCND2 and
EN1) following the expression of Flag-NIPP1
(Figure 4A). The expression of none of these genes was
affected in the Flag-NIPP1m cell line. CDC6, which is not
a PcG target, served as a negative control in these experi-
ments. ChIP with EZH2 and H3K27me3 antibodies con-
ﬁrmed that the six Flag-NIPP1 affected genes were PcG
targets in HTO cells, as revealed by the binding of EZH2
(Figure 4B) and trimethylation on H3K27 (Figure 4C).
Consistent with these ﬁndings, the trimethylation
of H3K27 was inversely correlated with the relative
transcript level (Figure 4D). Additional ChIP analyses
showed that the repression of FOXA1, MT1F and
C15ORF27 by Flag-NIPP1 was associated with an
increased EZH2 binding and trimethylation of H3K27 at
the promoter region (Figure 4E). These effects were not
observed after the expression of Flag-NIPP1m. A similar
analysis for ITGB2, CCND2 and EN1 revealed that their
increased transcript level after the expression of
Flag-NIPP1 was associated with a decreased EZH2
binding and trimethylation of H3K27 (Figure 4F).
Again, these effects were not seen after the expression
of Flag-NIPP1m. In conclusion, the overexpression
of NIPP1 results in an increased binding of EZH2
to a subset of PcG target genes, accounting for their
increased H3K27 trimethylation and repression.
In contrast, a distinct subset of PcG target genes
is upregulated following the overexpression of NIPP1,
and this correlates with a decreased binding of EZH2
and trimethylation of H3K27.
The association of NIPP1 with PcG target genes
depends on PP1
We noted that the PcG targets (ITGB2, CCND2 and EN1)
that were upregulated by an overexpression of NIPP1
were initially much more repressed than the
downregulated genes (FOXA1, MT1F and C15ORF27),
as suggested by considerable differences in the
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Figure 2. The downregulation of NIPP1 or PP1 is associated with a deﬁcient binding of EZH2 to PcG target genes. (A) The siRNA-mediated
knockdown (KD) of NIPP1 and PP1 (all three isoforms) in PC-3 cells was analyzed by immunoblotting with the indicated antibodies. Tubulin served
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bars) and CDC6 was used as a nontarget gene. ChIP enrichments were expressed as a percentage ± SEM (n=3) of the total input signal (B and C)
or as a percentage ± SEM (n=3) of the data obtained with the control siRNA (D and E). *P<0.05 with the paired Student’s t-test.
7504 Nucleic Acids Research, 2010,Vol.38, No. 21trimethylation of H3K27 (Figure 4C) and their relative
expression level (Figure 4D). Actually, this correlation
generally applied to the PcG target genes in the HTO
cells that were affected by the expression of Flag-NIPP1
in that the upregulated genes showed, on average, a much
lower basal transcript level (Supplementary Figure 1).
Therefore, one explanation for the upregulation of PcG
targets by overexpressed NIPP1 is that these genes cannot
bind additional NIPP1, possibly because they are already
saturated with NIPP1, resulting in a re-targeting
of associated EZH2 by overexpressed NIPP1 to PcG
genes that can still bind additional NIPP1. An alternative
explanation for the upregulation of a subset of PcG
targets is that overexpressed NIPP1 competitively
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Nucleic Acids Research, 2010,Vol.38, No. 21 7505disrupts the binding of PRC2 complexes to (other) chro-
matin recruiter proteins. The latter interpretation would
imply that PcG genes that are upregulated after
overexpression of NIPP1 are not direct NIPP1 targets.
Because of a discontinuity in the availability of NIPP1
antibodies of ChIP-grade, we made use of the DamID
technique as an alternative tool to study the association
of NIPP1 with PcG target genes in vivo (23,24). For that
purpose, methylation-speciﬁc restriction enzymes and
qPCR or microarrays were used to measure how the
targeting of bacterial DNA adenine methyltransferase
(Dam) that is fused to NIPP1 changes the pattern
of Dam-catalyzed DNA-methylation in a GATC context
(Figure 5A). HeLa cell lines stably expressing trace
amounts Dam, Dam fused to NIPP1, or Dam fused to
NIPP1m were generated. To rule out effects from the
random integration of the transgenes, we generated and
tested for each transgene two distinct polyclonal cell lines,
with identical results. The expression of the transgenes in
the different cell lines was veriﬁed by qRT-PCR (data not
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Figure 5. The association of Dam-NIPP1 with selected PcG target genes. (A) Scheme showing the chromatin targeting of Dam fused to NIPP1, resulting
in an increased local DNA methylation. (B) HEK293T cells were transfected with plasmids encoding Dam-NIPP1 or Dam-NIPP1m and the activator
plasmid pVgRXR, and treated with 2mM ponasterone A. Expression of fusion proteins was veriﬁed by immunoblotting using antibodies against NIPP1.
(C and D) The association of Dam, Dam-NIPP1 and Dam-NIPP1m with CDC6 (C) and the indicated PcG genes on ﬁve positions around the tran-
scriptional start site (D) was determined by the DamID procedure, using the same amount of total DNA for each sample. Relative abundance, as
measured by qPCR, was normalized to the Dam control. ChIP assays for EZH2 and H3K27me3 on the same locations of the indicated PcG targets were
performed in the Dam control cells. ChIPs with rabbit anti-mouse IgGs served as negative control (white bars) and ChIP enrichments were calculated as a
percentage of bound/input signal. The positions of the PCR amplicons (numbers 1–5) on each gene are indicated on scale. Exons are indicated by white
boxes and the transcriptional start site by an arrow. The data represent means ± SEM of three independent experiments.
Nucleic Acids Research, 2010,Vol.38, No. 21 7507shown). However, the very low expression level of the
Dam fusions, which is important to reduce nontargeted
background methylation (23), precluded a direct examin-
ation of their expression by immunoblotting. Therefore,
we made use of the ecdyson-inducible promoter in the
DamID vectors and veriﬁed that the used plasmids ex-
pressed similar levels of Dam-NIPP1 and Dam-NIPP1m,
following their transient transfection together with the
pVgRXR vector, which encodes the ecdyson receptor
(Figure 5B). This expression was entirely dependent on
the presence of the the ecdyson analogue Ponasterone A.
Using DamID analysis we found that, relative to Dam
alone, Dam-NIPP1 and Dam-NIPP1m did not bind to
the non-PcG target gene CDC6 (Figure 5C). However,
Dam-NIPP1 was associated with both subsets of the six
selected PcG target genes, and this largely correlated
with the binding of EZH2 and trimethylation of
H3K27 at ﬁve loci around the transcriptional start site
(Figure 5D). These results show that the upregulated as
well as the downregulated PcG genes are direct NIPP1
targets. In further agreement with this conclusion,
we found that both subsets of genes were upregulated
following the knockdown of NIPP1 in the parental
HTO cells (Supplementary Figure S2). Thus, a subset
of PcG target genes, including ITGB2, CCND2 and
EN1, are upregulated by the knockdown
(Supplementary Figure S2) as well as the overexpression
of NIPP1 (Figure 4A). Intriguingly, with nearly all
tested primer sets, the binding of Dam-NIPP1m to
the PcG targets was strongly reduced, as compared
to that of Dam-NIPP1 (Figure 5D), suggesting
that the targeting of NIPP1 to PcG targets is dependent
on PP1.
Mapping of NIPP1 chromatin binding sites
As an unbiased approach to study the association
of NIPP1 and NIPP1m with chromatin, the DamID prep-
arations were also analyzed by an ENCODE
(ENCyclopedia Of Dna Elements) microarray. This
array covers about 1% of the human genome (30Mb,
oligonucleotides of 25bp with 7-bp tiling) and comprises
coding, regulatory and intergenic regions. Independent
runs from two distinct polyclonal cell lines for each con-
dition showed numerous signiﬁcant binding peaks for
both Dam-NIPP1 and Dam-NIPP1m (Supplementary
Table S4). Out of the 16 genes on the array that were
predicted to be PcG targets based upon their
trimethylation on H3K27 and Suz12 binding in TIG3
cells (27), six contained signiﬁcant NIPP1 binding sites.
Various Dam-NIPP1 binding sites were identiﬁed in the
Homeobox (Hox) A cluster (Figure 6A), one of the best
characterized PcG targets (4,27). Consistent with a role for
NIPP1 in the binding of EZH2 to these genes, we found
that a knockdown of NIPP1 was associated with a signiﬁ-
cantly reduced occupancy of EZH2 at ﬁve of the six
analyzed Hox-A genes (Supplementary Figure S3).
Further, in accordance with the qPCR data on selected
PcG targets (Figure 5D), the Hox-A cluster generally
also showed a reduced binding of Dam-NIPP1m (Figure
6A). This did not apply, however, to the non-PcG NIPP1
binding sites, which comprised the large majority of the
Dam-NIPP1 and Dam-NIPP1m binding peaks. Indeed,
some non-PcG binding sites retained Dam-NIPP1 and
Dam-NIPP1m to a similar extent, while others bound
Dam-NIPP1m even better than they did Dam-NIPP1
(Figure 6B), indicating that the absence of NIPP1m
on PcG targets is not due to its inability to associate
with chromatin. These differential NIPP1 and NIPP1m
binding patterns were conﬁrmed by qPCR (Figure 6A
and B). Furthermore, we veriﬁed by ChIP analysis that
the Hox-A cluster was heavily trimethylated on H3K27,
unlike the regions that bound preferentially
Dam-NIPP1m or both Dam-NIPP1 and Dam-NIPP1m
(Figure 6C). Finally, a global analysis of the binding
peaks revealed that the binding of Dam-NIPP1 and
Dam-NIPP1m was relatively enriched at intronic
regions, at the expense of intergenic regions (Figure 6D).
In conclusion, the Dam-ID experiments revealed that both
NIPP1 and NIPP1m have numerous chromatin binding
sites, but the retention at a subset of PcG targets is largely
restricted to NIPP1, suggesting a key contribution for PP1
in the association of NIPP1 with these loci.
PP1 is not required for the assembly of the NIPP1–PRC2
complex
The above data are suggestive for a role of PP1 in the
recruitment of NIPP1 at speciﬁc PcG targets, but they
do not rule out a contribution of PP1 in the assembly
of the NIPP1-PRC2 complex. To address this issue, we
transiently expressed EGFP, NIPP1-EGFP
or NIPP1m-EGFP in HEK293T cells, isolated the
EGFP complexes using ‘GFP-trap’ beads, and analyzed
the complexes for the presence of PP1 and the PRC2 com-
ponents EZH2, SUZ12, EED and RbAp48 (Figure 7A).
All components, except for PP1, were similarly abundant
in the immunoprecipitates of NIPP1-EGFP and
NIPP1m-EGFP. Conversely, the PRC2 components
were also detected equally well in EZH2 immunopre-
cipitates after the expression of NIPP1-EGFP
or NIPP1m-EGFP (Figure 7B). Thus, PP1 does not
appear to be required for the assembly of the PRC2
complex or its association with NIPP1, but is involved
in the targeting or retention of the complex at a subset
of PcG target sites.
DISCUSSION
We have previously demonstrated that NIPP1 has distinct
binding sites for PP1 (16,22) and the PRC2 components
EZH2 (18) and EED (17). Here, we show that the
chromatin-associated fraction of NIPP1 and PP1, unlike
its soluble pool, forms a complex with the PRC2 complex,
as illustrated by reciprocal co-immunoprecipitation
experiments (Figures 1A and 7A) and the ability of recom-
binant NIPP1 to competitively disrupt the chromatin
binding of PRC2-type complexes (Figure 1B). This
complex also includes the PRC2 core components
SUZ12 and RbAp48, which do not interact directly with
NIPP1. Moreover, a microarray- and qPCR-based
DamID analysis (Figures 5 and 6) conﬁrmed and
7508 Nucleic Acids Research, 2010,Vol.38, No. 21extended previous ChIP data (19), showing that NIPP1
binds to PcG target sites. Among the newly identiﬁed
NIPP1 targets is the Hox A cluster (Figure 6A), which
belongs to the ﬁrst and best characterized PcG targets
(4,27). Unexpectedly, the DamID analysis also identiﬁed
numerous NIPP1 chromatin-binding sites that were
remote from PcG targets, indicating that NIPP1 also has
chromatin-associated functions unrelated to PcG
signaling. This is in accordance with previous ﬁndings
showing that NIPP1 binds to RNA (26), is complexed to
the splicing factors SAP155 (28) and CDC5L (29), and has
a role in (alternative) pre-mRNA splicing (21,30).
It indeed seems likely that Dam-NIPP1, as a component
of the spliceosomes or splicing enhancer/silencing
complexes, also leaves methylation marks on neighboring
DNA during co-transcriptional (alternative) splicing.
However, it cannot be ruled out that the transcriptional
and splicing functions of NIPP1 are somehow connected.
For example, the NIPP1 ligand and splicing factor
SAP155 also functions as a linker between the PRC2
and PRC1 complex (31). Moreover, NIPP1 binds with
high afﬁnity to RNA (26) and noncoding RNAs have
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Nucleic Acids Research, 2010,Vol.38, No. 21 7509been implicated in the recruitment of PRC complexes
(2,3,5,8). It will therefore be interesting to investigate
whether NIPP1 regulates the targeting of PRC2-type
complexes by an RNA-guided mechanism.
Our observation that NIPP1 interacts with PcG target
genes as well as with the PRC2 complex makes it a prime
candidate-regulator of PRC2 recruitment. Consistent with
this notion, we found that the knockdown of NIPP1
resulted in a loss of EZH2 from PcG target genes and
a decreased trimethylation of H3K27 (Figure 2 and
Supplementary Figure S3). Conversely, the stable
overexpression of NIPP1 caused a redistribution
of EZH2 among PcG target genes, with corresponding
changes in H3K27 trimethylation (Figure 4).
Intriguingly, overexpressed NIPP1 redistributed EZH2
from maximally repressed PcG targets to genes that
were still partially active (Figure 4D). Yet, both sets
of PcG genes were direct NIPP1 targets, as suggested by
DamID analysis (Figure 5) and their increased expression
following the knockdown of NIPP1 (Supplementary
Figure S2). Collectively, these data suggest that maximally
repressed PcG target genes are no longer accessible
to overexpressed NIPP1 or are already saturated
with NIPP1. In either case, the redistribution of EZH2
can be explained by the competitive disruption of the
PRC2-type complexes from fully repressed genes
and their re-targeting to genes that bind the overexpressed
NIPP1. At present, we do not know whether NIPP1
remains associated with PcG target genes once the
PRC2 complex is recruited. It is possible that NIPP1
is only transiently associated with PcG targets and dissoci-
ates again once a chromatin structure is established that
stabilizes the binding of PRC2. In this respect, it is import-
ant to note that the PRC2 complex and EED (13,14) have
recently been shown to bind directly to trimethylated
H3K27, which could represent a mechanism to keep
PcG targets silenced once the triggers of their initial
inactivation are gone. We also want to point out that
the recruitment of PRC complexes in Drosophila
is complexly regulated by multiple proteins (3). It seems
likely that vertebrates also express multiple PRC recruiters
or recruiter regulating proteins, as has been suggested
recently (5). Additional PcG recruiter (regulating)
proteins may act independently or in concert with NIPP1.
Intriguingly, the PP1-binding mutant NIPP1m still
fractionated with chromatin (Figure 3D) and interacted
with the PRC2 complex (Figure 7A). Yet, NIPP1m only
had minor effects on transcription (Figure 3) and on the
distribution and function of EZH2 (Figure 4). This is good
evidence that NIPP1-associated PP1 plays a key role in
NIPP1-regulated PRC2 signaling. Strikingly, we mapped
numerous chromatin-binding sites for both NIPP1 and
NIPP1m (Supplementary Table 4), but NIPP1m was con-
spicuously less associated with PcG targets (Figures 5
and 6). This suggests that NIPP1-associated PP1 is specif-
ically needed for the targeting of NIPP1 to a subset of PcG
loci. Interestingly, phosphorylation of PcG proteins is
generally associated with their dissociation from chroma-
tin (32). For example, the phosphorylation of EZH2 on
Ser21 precludes its association with chromatin (33).
However, the phosphorylation of this site was not differ-
ent between Wt and NIPP1
/– blastocyst outgrowths (20).
PP1-interacting proteins often act themselves as substrates
or substrate targeting subunits (34). However, metabolic
labeling experiments of the HTO cell lines with
32P-labeled
Pi did not disclose a different extent of phosphorylation
of NIPP1 and NIPP1m, or their co-immunoprecipitating
proteins (our unpublished data). Therefore, the
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Figure 7. NIPP1-associated PP1 is not required for the NIPP1–PRC2 interaction. HEK293T cells were transfected with plasmids encoding EGFP,
NIPP1-EGFP and NIPP1m-EGFP. The EGFP-fusions (A) and EZH2 (B) were immunoprecipitated from the micrococcal nuclease-solubilized
chromatin fraction with the GFP-trap and anti-EZH2 antibodies, respectively. EGFP and IgG’s were used as a negative control for
the GFP-trap and EZH2 IP, respectively. NIPP1, EZH2, SUZ12, EED, RbAp48 and PP1 were detected by immunoblotting in the input
(In, 5–10%), the GFP-trap and the immunoprecipitates (IP).
7510 Nucleic Acids Research, 2010,Vol.38, No. 21substrate(s) of NIPP1-associated PP1 that enable the bind-
ing of NIPP1 to PcG targets remain elusive and it can
currently even not be ruled out entirely that the role
of NIPP1-associated PP1 is structural rather than
catalytic.
In conclusion, we have found that NIPP1 modulates the
binding of the PRC2 complex to at least a subset of its
target genes. The binding of NIPP1 to these genes depends
on associated PP1, disclosing a novel interaction between
PcG signaling and PP1.
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